schizophrenia |
107 |
covid-19 |
93 |
depression |
92 |
humans |
92 |
adult |
81 |
female |
79 |
male |
71 |
hong kong |
69 |
adolescent |
65 |
chinese |
61 |
psychosis |
60 |
aged |
59 |
risk factors |
59 |
middle aged |
57 |
first-episode psychosis |
51 |
genetic predisposition to disease |
51 |
anxiety |
49 |
dementia |
49 |
depressive symptoms |
48 |
genotype |
48 |
asian continental ancestry group - genetics |
47 |
mental health |
47 |
polymorphism, single nucleotide |
47 |
epidemiology |
46 |
negative symptoms |
44 |
psychotic disorders |
44 |
youth mental health |
44 |
medical sciences |
42 |
meta-analysis |
42 |
young adult |
40 |
early intervention |
38 |
early psychosis |
35 |
genome-wide association study |
34 |
polymorphism, single nucleotide - genetics |
34 |
prevalence |
34 |
older adults |
33 |
antipsychotics |
32 |
age factors |
31 |
cognition |
31 |
cognitive impairment |
31 |
functioning |
31 |
randomized controlled trial |
31 |
china |
30 |
psychopathology |
30 |
child |
29 |
first-episode schizophrenia |
29 |
predictors |
29 |
cost-effectiveness |
28 |
genetic association |
28 |
hong kong - epidemiology |
28 |
interprofessional education |
28 |
network analysis |
28 |
partnership model |
28 |
sex factors |
28 |
social interaction anxiety |
28 |
genetics |
27 |
incidence |
27 |
psychiatry and neurology |
27 |
stigma |
27 |
first episode |
26 |
mortality |
26 |
physical activity |
26 |
social unrest |
26 |
stress |
26 |
insomnia |
25 |
recurrence |
25 |
relapse |
25 |
single nucleotide polymorphism |
25 |
risk factor |
24 |
sars-cov-2 |
24 |
time factors |
24 |
association |
23 |
dopamine |
23 |
executive function |
23 |
human |
23 |
magnetic resonance imaging |
23 |
remission |
23 |
adolescents |
22 |
case-control studies |
22 |
duration of untreated psychosis |
22 |
exercise |
22 |
hospitalization |
22 |
post-traumatic stress disorder |
22 |
quality of life |
22 |
animals |
21 |
cell adhesion molecules - genetics |
21 |
cognitive function |
21 |
cohort studies |
21 |
gene frequency |
21 |
loneliness |
21 |
rumination |
21 |
schizophrenic psychology |
21 |
sleep |
21 |
systematic review |
21 |
aged, 80 and over |
20 |
asian continental ancestry group |
20 |
assessment |
20 |
bipolar disorder |
20 |
ischemic stroke |
20 |
longitudinal |
20 |
mri |
20 |
treatment outcome |
20 |
type 2 diabetes |
20 |
age of onset |
19 |
cluster analysis |
19 |
disease progression |
19 |
insight |
19 |
medication adherence |
19 |
priority journal |
19 |
questionnaires |
19 |
acupuncture |
18 |
age distribution |
18 |
amotivation |
18 |
antigens, cd - genetics |
18 |
comorbidity |
18 |
coronary artery disease |
18 |
elderly |
18 |
first-episode |
18 |
gene expression regulation, neoplastic |
18 |
gwas |
18 |
mindfulness |
18 |
obesity |
18 |
prevention |
18 |
prognosis |
18 |
psychiatric status rating scales |
18 |
severity of illness index |
18 |
whole-exome sequencing |
18 |
controlled study |
17 |
cross-sectional studies |
17 |
longitudinal studies |
17 |
major clinical study |
17 |
mendelian randomization |
17 |
suicide |
17 |
antidepressants |
16 |
antipsychotic agents - therapeutic use |
16 |
avolition |
16 |
brain - pathology |
16 |
child psychosocial problems |
16 |
copy number variation |
16 |
coronavirus |
16 |
delusional disorder |
16 |
employment |
16 |
functional outcome |
16 |
home confinement |
16 |
pregnancy |
16 |
promoter regions, genetic |
16 |
public health |
16 |
school closure |
16 |
alzheimer's disease |
15 |
asian |
15 |
atrial fibrillation |
15 |
body mass index |
15 |
cancer |
15 |
development |
15 |
diffusion tensor imaging |
15 |
follow-up studies |
15 |
gene identification |
15 |
gene locus |
15 |
hypertension |
15 |
l-lactate dehydrogenase - blood |
15 |
linkage disequilibrium |
15 |
memory |
15 |
mental disorders |
15 |
mice |
15 |
neuregulin-1 - genetics |
15 |
neuropsychological tests |
15 |
prediction |
15 |
predictive value of tests |
15 |
rct |
15 |
self-stigma |
15 |
sleep disturbance |
15 |
suicidal ideation |
15 |
alleles |
14 |
antipsychotic |
14 |
caregivers |
14 |
chemicals and cas registry numbers |
14 |
child, preschool |
14 |
complications |
14 |
coronavirus infection |
14 |
effectiveness |
14 |
experience sampling method |
14 |
gender |
14 |
gene expression |
14 |
genetic variation |
14 |
haplotypes |
14 |
health outcomes |
14 |
hippocampus |
14 |
likelihood functions |
14 |
longitudinal study |
14 |
mental health services |
14 |
metabolic syndrome |
14 |
outcome |
14 |
pandemic |
14 |
psychotic disorders - diagnosis |
14 |
review |
14 |
sars |
14 |
smartphone overuse |
14 |
social cognition |
14 |
social support |
14 |
systemic lupus erythematosus |
14 |
adherence |
13 |
adverse events |
13 |
anhedonia |
13 |
bile duct atresia |
13 |
cancer susceptibility genes |
13 |
china - epidemiology |
13 |
chromosome 10q |
13 |
collaborative stepped care |
13 |
early diagnosis |
13 |
early-age onset |
13 |
gene function |
13 |
genetic susceptibility |
13 |
genome-wide association |
13 |
hepatocellular carcinoma |
13 |
hirschsprung disease |
13 |
hirschsprung disease - genetics |
13 |
interleukin-6 |
13 |
lipocalin-2 |
13 |
magnetic resonance imaging - methods |
13 |
mst1r |
13 |
nasopharyngeal carcinoma |
13 |
neurocognition |
13 |
peer support |
13 |
premorbid adjustment |
13 |
prospective study |
13 |
receptors, cell surface - genetics |
13 |
recovery |
13 |
regression analysis |
13 |
resilience |
13 |
secondary prevention |
13 |
symptomatology |
13 |
validation |
13 |
validation study |
13 |
violence |
13 |
vitamin d |
13 |
working memory |
13 |
young people |
13 |
aging |
12 |
animal tissue |
12 |
anorectal malformation |
12 |
anxiety disorder |
12 |
attitude |
12 |
autism spectrum disorder |
12 |
brain |
12 |
chromosome aberration |
12 |
classification |
12 |
cos cells |
12 |
early detection |
12 |
electrophoretic mobility shift assay |
12 |
endophenotype |
12 |
ephrin-a2 - genetics |
12 |
evaluation |
12 |
gene mapping |
12 |
genetic predisposition to disease - genetics |
12 |
gwa |
12 |
lupus erythematosus, systemic - genetics |
12 |
maintenance |
12 |
mild cognitive impairment |
12 |
momentary positive affect |
12 |
mutation - genetics |
12 |
mutations |
12 |
myocardial infarction |
12 |
pleiotropy |
12 |
poisson distribution |
12 |
prospective studies |
12 |
relapse prevention |
12 |
ret |
12 |
reverse transcriptase polymerase chain reaction |
12 |
schizophrenia - complications |
12 |
schizotypal personality disorder |
12 |
severe acute respiratory syndrome - blood - genetics |
12 |
sle |
12 |
snp |
12 |
socioeconomic factors |
12 |
survival |
12 |
theory of mind |
12 |
uhrf1bp1 |
12 |
united states - epidemiology |
12 |
wnt signaling pathway |
12 |
affect |
11 |
antigens, cd3 - genetics |
11 |
asia |
11 |
bmd |
11 |
breast cancer |
11 |
cd247 |
11 |
clozapine |
11 |
community |
11 |
databases, genetic |
11 |
diabetes |
11 |
diminished expression |
11 |
ethnic group |
11 |
gene mutation |
11 |
genetic polymorphism |
11 |
genetic predisposition |
11 |
genomics |
11 |
heterozygote |
11 |
human tissue |
11 |
infant |
11 |
influenza |
11 |
intervention |
11 |
kw034 - copy number/structural variation |
11 |
long-term outcomes |
11 |
longitudinal follow-up |
11 |
lupus erythematosus, systemic - genetics - immunology |
11 |
maintenance treatment |
11 |
mass screening |
11 |
nucleotide sequence |
11 |
odds ratio |
11 |
osteoporosis |
11 |
pattern glare |
11 |
perceptual distortions |
11 |
personality |
11 |
polymorphism, genetic |
11 |
positron emission tomography |
11 |
processing speed |
11 |
prospective follow-up |
11 |
risk |
11 |
risk assessment |
11 |
self-reference |
11 |
sex difference |
11 |
treatment adherence |
11 |
whole exome sequencing |
11 |
youth |
11 |
25-hydroxyvitamin d |
10 |
adipocyte |
10 |
algorithms |
10 |
amino acid substitution |
10 |
b-type natriuretic peptide |
10 |
biomarkers |
10 |
bone density - genetics |
10 |
cardiac troponin |
10 |
causality |
10 |
cell adhesion molecules - genetics - metabolism |
10 |
cognitive decline |
10 |
cognitive functions |
10 |
cohort study |
10 |
community-based intervention |
10 |
computer simulation |
10 |
covid-19 vaccine |
10 |
delirium |
10 |
diagnosis |
10 |
discontinuation |
10 |
disengagement |
10 |
double blind |
10 |
exome chip |
10 |
f-dopa |
10 |
family health |
10 |
fibroblast growth factor |
10 |
functional connectivity |
10 |
genetics, population |
10 |
genome scan |
10 |
genome-wide association studies |
10 |
genotype-phenotype correlations |
10 |
heritability |
10 |
inflammation |
10 |
intracellular signaling peptides and proteins - genetics |
10 |
lactate dehydrogenase |
10 |
lumbar disc degeneration |
10 |
lupus erythematosus, systemic - enzymology - genetics |
10 |
major depressive episode |
10 |
mapping complex traits |
10 |
mental health literacy |
10 |
mindfulness-based intervention |
10 |
models, statistical |
10 |
momentary assessment |
10 |
neuropsychology |
10 |
nuclear proteins - genetics - metabolism |
10 |
pasc |
10 |
placebo |
10 |
post-acute sequelae of sars-cov-2 |
10 |
protein binding - genetics |
10 |
psychotic-like experiences |
10 |
rare complex disease |
10 |
registries |
10 |
reproducibility of results |
10 |
risk prediction |
10 |
schizophrenia - diagnosis |
10 |
social context |
10 |
stereotyping |
10 |
striatal dopamine capacity synthesis |
10 |
survival rate |
10 |
transcription factors - genetics - metabolism |
10 |
type 2 diabetes mellitus |
10 |
vaccine safety |
10 |
vitamin d-binding protein |
10 |
voxel-based morphometry |
10 |
youth-friendly |
10 |
air pollution |
9 |
asian-specific |
9 |
association study |
9 |
autistic disorder |
9 |
balloon analogue risk task |
9 |
bipolar |
9 |
cardiovascular disease |
9 |
chromosomes, human, pair 6 - genetics |
9 |
cognition disorders - etiology |
9 |
cognitive dysfunction |
9 |
delusions |
9 |
delusions - etiology |
9 |
depressive mood |
9 |
dti |
9 |
early medical intervention - methods - trends |
9 |
epidemiologic methods |
9 |
epidemiological study |
9 |
epidemiological youth |
9 |
esm |
9 |
exome-chip association analysis |
9 |
expression quantitative trait loci |
9 |
first episode psychosis |
9 |
fracture |
9 |
gene |
9 |
hallucination |
9 |
health education - methods |
9 |
ideas of reference |
9 |
internalized stigma |
9 |
language |
9 |
life events |
9 |
linkage |
9 |
lithium |
9 |
lumbar vertebrae |
9 |
machine learning |
9 |
major depressive disorder |
9 |
mass screening - methods |
9 |
mental health services - trends |
9 |
motivational deficits |
9 |
mutation |
9 |
natural selection |
9 |
omicron |
9 |
panss |
9 |
pax4 |
9 |
pedigree |
9 |
prodrome |
9 |
program development |
9 |
psychotic disorders - therapy |
9 |
public stigma |
9 |
receptors, calcitriol - genetics |
9 |
reward |
9 |
schizophrenia - pathology |
9 |
screening |
9 |
sex characteristics |
9 |
smoking |
9 |
software |
9 |
stability |
9 |
stigmatization |
9 |
tai chi |
9 |
traumatic events |
9 |
treatment |
9 |
adiponectin - blood - genetics |
8 |
age-period-cohort |
8 |
alcoholism |
8 |
allelic imbalance |
8 |
amygdala |
8 |
asian continental ancestry group - ethnology |
8 |
at-risk mental state |
8 |
bioinformatics |
8 |
blood pressure - genetics |
8 |
brain - ultrastructure |
8 |
breast neoplasms |
8 |
caudate |
8 |
cdars |
8 |
cell adhesion molecules - genetics - physiology |
8 |
cell differentiation - physiology |
8 |
chi-square distribution |
8 |
cohort |
8 |
colorectal cancer |
8 |
computational biology |
8 |
corpus striatum |
8 |
cost of illness |
8 |
culture |
8 |
cyclin a2 |
8 |
degeneration |
8 |
degenerative disc disease |
8 |
delusions - diagnosis |
8 |
diabetes mellitus |
8 |
diabetic retinopathy |
8 |
disc |
8 |
disease models, animal |
8 |
disease outbreaks - statistics & numerical data |
8 |
disease susceptibility |
8 |
dna mutational analysis |
8 |
dose-dependent effect |
8 |
double-blind method |
8 |
drug-naive |
8 |
ecological momentary assessment |
8 |
environment |
8 |
european continental ancestry group - statistics & numerical data |
8 |
exercise - physiology |
8 |
eye-gaze perception |
8 |
fractional anisotropy |
8 |
frailty |
8 |
gender difference |
8 |
gene deletion |
8 |
gene duplication |
8 |
gene expression regulation |
8 |
gene frequency - genetics |
8 |
genetic variants |
8 |
genetic variation - genetics |
8 |
growth mixture modeling |
8 |
haplotype |
8 |
hbv integration |
8 |
hcc |
8 |
hedgehog proteins - genetics - metabolism |
8 |
hirschsprung disease - genetics - physiopathology |
8 |
homozygote |
8 |
hypertension - blood - genetics |
8 |
infant, newborn |
8 |
insr |
8 |
insulin resistance - genetics |
8 |
intervertebral |
8 |
intervertebral disc degeneration |
8 |
interview, psychological - methods |
8 |
japan |
8 |
ketamine |
8 |
kw080 - genome-wide association |
8 |
latent class analysis |
8 |
latent class growth analysis |
8 |
lectins, c-type - genetics |
8 |
life tables |
8 |
long-term outcome |
8 |
lumbar |
8 |
maternal age |
8 |
maternal exposure |
8 |
mathematics |
8 |
mental health services - standards |
8 |
mentalization |
8 |
meta analysis |
8 |
mode of onset |
8 |
models, genetic |
8 |
multivariate analysis |
8 |
nasopharyngeal neoplasms - genetics |
8 |
neurobiology |
8 |
neuroglia - cytology - physiology |
8 |
obesity - genetics |
8 |
outbreak |
8 |
p300 |
8 |
path analysis |
8 |
persistent psychotic experience |
8 |
phenotyping |
8 |
polygenic score |
8 |
population-based |
8 |
potassium channels, inwardly rectifying - genetics |
8 |
prenatal exome |
8 |
primary negative symptoms |
8 |
proliferative diabetic retinopathy |
8 |
promoter regions, genetic - genetics |
8 |
proteins - genetics |
8 |
psychosocial |
8 |
psychotic disorder |
8 |
psychotic disorders - complications |
8 |
psychotic symptoms |
8 |
ptsd symptoms |
8 |
qigong |
8 |
raclopride |
8 |
receptors, notch - genetics - metabolism |
8 |
reliability |
8 |
sars virus - isolation and purification - pathogenicity |
8 |
schizophrenia - drug therapy - physiopathology |
8 |
schizophrenia - genetics |
8 |
second-generation antipsychotics |
8 |
self-discrepancy |
8 |
self-harm |
8 |
semantic |
8 |
sensitivity and specificity |
8 |
severe acute respiratory syndrome - physiopathology - virology |
8 |
sight-threatening diabetic retinopathy |
8 |
single nucleotide polymorphisms |
8 |
single-nucleotide polymorphism |
8 |
spirituality |
8 |
splicing |
8 |
substance abuse |
8 |
temporal lobe - ultrastructure |
8 |
terminology as topic |
8 |
traditional chinese medicine |
8 |
trauma exposure |
8 |
treatment resistant schizophrenia |
8 |
variants of unknown clinical significance |
8 |
web-based |
8 |
5' untranslated regions - genetics |
7 |
actigraphy |
7 |
adaptation, psychological |
7 |
adolescent idiopathic scoliosis |
7 |
aggression |
7 |
air pollution - adverse effects |
7 |
alkaline phosphatase |
7 |
als |
7 |
amino acid substitution - genetics |
7 |
analgesia |
7 |
anti-stigma campaigns |
7 |
antigens, cd11b - genetics |
7 |
antipsychotic agents - administration and dosage |
7 |
antipsychotic agents - pharmacology - therapeutic use |
7 |
asian americans - statistics & numerical data |
7 |
asian continental ancestry group - ethnology - genetics |
7 |
attitude to health |
7 |
behavior |
7 |
behavior, animal |
7 |
behavioral symptoms - etiology - psychology - therapy |
7 |
big five |
7 |
biliary |
7 |
biological markers |
7 |
biology |
7 |
biomarker |
7 |
blood pressure |
7 |
bone mineral density |
7 |
bone/joint abnormalities |
7 |
breast neoplasms - epidemiology |
7 |
breast neoplasms - epidemiology - ethnology - mortality |
7 |
c-reactive protein |
7 |
carcinoma, ductal, breast - epidemiology - ethnology - mortality |
7 |
cardiovascular diseases |
7 |
caregiving |
7 |
cartilage |
7 |
cartilage diseases - genetics |
7 |
categorization |
7 |
cd209 |
7 |
cell line |
7 |
cer1 |
7 |
charcot-marie-tooth |
7 |
charcot-marie-tooth disease - genetics - pathology - physiopathology |
7 |
chinese population |
7 |
cholangiogram |
7 |
chromosome mapping - methods |
7 |
cognitive structure |
7 |
col4a5 |
7 |
col4a6 |
7 |
complex traits and polygenic disorders |
7 |
connexins - genetics |
7 |
content-dependent process |
7 |
coping strategies |
7 |
correlates |
7 |
course |
7 |
dc-sign |
7 |
de novo mutations |
7 |
dementia and cognitive disorders |
7 |
developed countries - statistics & numerical data |
7 |
diagnostic and statistical manual of mental disorders |
7 |
directed differentiation |
7 |
discriminant analysis |
7 |
discrimination |
7 |
dna - metabolism |
7 |
dna probes - genetics |
7 |
dsm-5 |
7 |
duration of untreated psychosis (dup) |
7 |
educational status |
7 |
effort-cost computation |
7 |
electroacupuncture |
7 |
electromyography |
7 |
ens |
7 |
executive function - physiology |
7 |
exome |
7 |
extended early intervention |
7 |
extracellular matrix proteins - chemistry - genetics |
7 |
extracellular matrix proteins - genetics - physiology |
7 |
fatty acid-binding proteins - blood |
7 |
first-episode schizophrenia spectrum disorder |
7 |
functional mri |
7 |
functional remission |
7 |
gene library |
7 |
genes |
7 |
genetic correlation |
7 |
genetic diseases, x-linked - genetics |
7 |
genetic mapping |
7 |
genome |
7 |
gjb1 (connexin32) |
7 |
gonosomal mosaicism |
7 |
han chinese |
7 |
haplotypes - genetics |
7 |
health economic analysis |
7 |
health service accessibility |
7 |
health surveys |
7 |
hela cells |
7 |
help-seeking |
7 |
help‐seeking |
7 |
human induced pluripotent stem cells |
7 |
illness disclosure |
7 |
influenza, human - complications - mortality - therapy |
7 |
integrative body-mind-spirit (ibms) |
7 |
internet |
7 |
intervertebral disc - pathology |
7 |
intervertebral disc disease |
7 |
intervertebral disk |
7 |
intervertebral disk displacement - complications - epidemiology - genetics |
7 |
interview, psychological |
7 |
interviews as topic |
7 |
isolated diffuse oesophageal leiomyomatosis |
7 |
kw040 - development |
7 |
kw065 - gastrointestinal system |
7 |
kw099 - malformation |
7 |
late-onset psychosis |
7 |
lateral ventricles |
7 |
lectins, c-type - genetics - metabolism |
7 |
letter |
7 |
life expectancy |
7 |
life style |
7 |
life table |
7 |
linkage analysis |
7 |
lipids |
7 |
long-term follow-up |
7 |
longitudinal course |
7 |
lupus erythematosus, systemic - ethnology - genetics |
7 |
magnetic resonance cholangiography |
7 |
matrix metalloproteinase 1 - genetics |
7 |
medication-naïve |
7 |
mental health assessments |
7 |
mental health services - organization and administration |
7 |
mhealth |
7 |
microscopy, electron, transmission |
7 |
morbidity |
7 |
morphine consumption |
7 |
motivational impairment |
7 |
mutation detection |
7 |
nephritis - ethnology - genetics |
7 |
network |
7 |
neural conduction - genetics - physiology |
7 |
neural crest |
7 |
neuregulin 1 |
7 |
neuropathy |
7 |
next generation sequencing |
7 |
nomenclature |
7 |
non-coding region |
7 |
notochord-like cells (ncls) |
7 |
nuclear proteins - metabolism |
7 |
nucleus pulposus (np)-like cells |
7 |
nursing home |
7 |
obstetric complications |
7 |
osteoarthritis |
7 |
overcontrolled |
7 |
pain |
7 |
parkinson's disease |
7 |
paternal age |
7 |
pathways |
7 |
peripheral nerves - pathology - physiopathology - ultrastructure |
7 |
persistent primary negative symptoms |
7 |
point mutation - genetics |
7 |
polymorphism |
7 |
pre-existing mental disorders |
7 |
prenatal exposure delayed effects |
7 |
probability |
7 |
psychiatric patients |
7 |
psychoeducation |
7 |
psychotherapy - methods |
7 |
psychotic disorders - diagnosis - drug therapy - therapy |
7 |
psychotic disorders - diagnosis - psychology |
7 |
psychotic disorders - drug therapy |
7 |
ptsd symptoms, women mental health |
7 |
public health and safety |
7 |
pyrophosphatases - genetics - physiology |
7 |
quantitative trait loci |
7 |
randomized controlled trials as topic |
7 |
rare variants |
7 |
rats |
7 |
real-world functioning |
7 |
receptors, cell surface - genetics - metabolism |
7 |
rehospitalization |
7 |
remission induction |
7 |
resilient |
7 |
retrospective studies |
7 |
risk taking |
7 |
schizophrenia - complications - diagnosis - epidemiology - therapy |
7 |
schizophrenia - drug therapy |
7 |
schizophrenia - drug therapy - pathology |
7 |
schizophrenia-spectrum disorder |
7 |
schizotypy |
7 |
seasons |
7 |
seer program |
7 |
sequence analysis |
7 |
sex differences |
7 |
signal transduction - genetics |
7 |
six elements |
7 |
social class |
7 |
social functioning |
7 |
social stigma |
7 |
sociodemographic correlates |
7 |
sp1 transcription factor - genetics |
7 |
spinal diseases - genetics |
7 |
spontaneously reported symptoms |
7 |
statistics, nonparametric |
7 |
stress/burden |
7 |
stressful life event |
7 |
suicide, attempted - psychology |
7 |
survey |
7 |
symptom classification |
7 |
transcription factor ap-2 - genetics |
7 |
transfection |
7 |
treatment delay |
7 |
treatment-resistant schizophrenia |
7 |
triage |
7 |
undercontrolled |
7 |
v266l |
7 |
validity |
7 |
valine |
7 |
variant prioritization |
7 |
vertebral disk displumbar vertebrae |
7 |
5' untranslated region |
6 |
actor-partner interdependence model |
6 |
adhd |
6 |
adiponectin |
6 |
adiponectin - genetics |
6 |
adipose tissue - chemistry |
6 |
adrenomedullin |
6 |
adults |
6 |
affective psychoses |
6 |
aging - pathology |
6 |
aging in place |
6 |
alanine |
6 |
alff |
6 |
alzheimer disease - pathology |
6 |
anisotropy |
6 |
anorectal malformations |
6 |
anti-psychotics |
6 |
antidepressant |
6 |
antipsychotic agents - administration and dosage - therapeutic use |
6 |
anxiety disorders |
6 |
app |
6 |
area under curve |
6 |
arhgap4 |
6 |
asia - epidemiology |
6 |
asociality |
6 |
at-risk mental states |
6 |
atherosclerosis |
6 |
attention |
6 |
attention deficit hyperactivity disorder |
6 |
at‐risk mental state |
6 |
autism |
6 |
back pain - diagnosis - epidemiology |
6 |
biological markers - blood - metabolism |
6 |
biomedicine |
6 |
blinking |
6 |
blood glucose - analysis |
6 |
bone density |
6 |
bone loss |
6 |
bone mineral testing |
6 |
brain - drug effects - metabolism - pathology |
6 |
burkholderia pseudomallei |
6 |
cancer stem cell |
6 |
cancer stemness |
6 |
carcinoma, papillary - genetics - metabolism - pathology |
6 |
cardiovascular diseases - mortality |
6 |
carrier proteins - genetics |
6 |
category fluency |
6 |
cause of death |
6 |
cbt |
6 |
cell adhesion molecules - blood |
6 |
cell proliferation |
6 |
cell transformation, neoplastic - genetics - metabolism |
6 |
checklist |
6 |
children |
6 |
chinese zodiac signs |
6 |
chizophrenia |
6 |
choledochal cyst |
6 |
chromosome 8p |
6 |
chromosomes, human, pair 3 - genetics |
6 |
chromosomes, human, pair 9 |
6 |
chronological age |
6 |
chronotype |
6 |
clinical high‐risk |
6 |
clinical predictors |
6 |
clozapine-resistant schizophrenia |
6 |
clustering |
6 |
cognition disorders - psychology |
6 |
cognitive clusters |
6 |
cognitive flexibility |
6 |
cognitive functioning |
6 |
cognitive heterogeneity |
6 |
cognitive insights |
6 |
col9a2 |
6 |
col9a3 |
6 |
collagen |
6 |
collagen type ix - genetics |
6 |
communityolder |
6 |
complete |
6 |
compliance |
6 |
concepts |
6 |
confounding |
6 |
contact tracing |
6 |
coping styles |
6 |
cox model |
6 |
cross infection - epidemiology - prevention & control - transmission |
6 |
cultural sensitivity |
6 |
cytokines - genetics |
6 |
data mining |
6 |
data repository |
6 |
de novo |
6 |
delivery of health care - standards |
6 |
demography |
6 |
developmental |
6 |
diabetes mellitus, type 2 - diagnosis - ethnology - genetics |
6 |
dibenzothiazepines - therapeutic use |
6 |
diffusivity |
6 |
digit symbol test |
6 |
digital technologies |
6 |
disease outbreaks |
6 |
disease outbreaks - prevention & control - statistics & numerical data |
6 |
dna-binding proteins - genetics - metabolism |
6 |
donepezil |
6 |
down syndrome |
6 |
drug naïve |
6 |
dsm-iv-tr |
6 |
dysglycemia |
6 |
early intervention service |
6 |
early medical intervention - standards |
6 |
effect modification |
6 |
effort allocation |
6 |
effort discounting |
6 |
effort-based decision-making |
6 |
electroencephalography |
6 |
emotion |
6 |
endophenotypes |
6 |
england - epidemiology |
6 |
environmental stressors |
6 |
erbb4 |
6 |
ethnic minority |
6 |
everyday cognitive function |
6 |
exon |
6 |
facial emotion perception |
6 |
family functioning |
6 |
fiber tracking |
6 |
fibrinogen |
6 |
fibrinogen - genetics - metabolism |
6 |
fitmind |
6 |
founder mutation |
6 |
fractionation |
6 |
fractures, bone - genetics |
6 |
gamma-glutamyltransferase - blood - metabolism |
6 |
gender differences |
6 |
gene cluster |
6 |
genetic disease |
6 |
genetic epidemiology |
6 |
genetic linkage |
6 |
genetic linkage - genetics |
6 |
genome, human |
6 |
genome-wide haplotype association mapping (ham) |
6 |
germ-line mutation |
6 |
ggt |
6 |
gli3 |
6 |
global cognitive function |
6 |
global functioning |
6 |
glucose intolerance - blood - genetics |
6 |
goiter, nodular - genetics - metabolism - pathology |
6 |
guideline |
6 |
hepatitis b |
6 |
history |
6 |
homeostasis |
6 |
hong kong - epidemiology - ethnology |
6 |
hospitalization - statistics & numerical data |
6 |
human genetics |
6 |
hyperglycaemia |
6 |
hypertension - blood - enzymology - epidemiology |
6 |
hypertension - blood - epidemiology - genetics |
6 |
hypertension - blood - ethnology - genetics - physiopathology |
6 |
hypertension - epidemiology |
6 |
hypertriglyceridemia - epidemiology |
6 |
icd-10 |
6 |
icsd-2 |
6 |
igt |
6 |
illness attributional belief |
6 |
image processing, computer-assisted - methods |
6 |
immersive |
6 |
immunoblotting |
6 |
immunohistochemistry |
6 |
impaired glucose tolerance |
6 |
in situ hybridization |
6 |
infection control |
6 |
insulin |
6 |
insulin resistance |
6 |
intellectual disability |
6 |
interleukin-6 - blood - genetics |
6 |
internal feed-forward |
6 |
internal medicine |
6 |
intervertebral disc displacement - diagnosis - epidemiology |
6 |
intervertebral disc displacement - epidemiology - genetics |
6 |
intervertebral disc herniation |
6 |
knowledge |
6 |
labelling |
6 |
late-life depression |
6 |
lifetime prevalence |
6 |
liver carcinogenesis |
6 |
liver function test |
6 |
locomotion |
6 |
lod score |
6 |
logistic models |
6 |
long-term trajectories |
6 |
longitudinal negative symptoms |
6 |
loss of heterozygosity |
6 |
low back pain |
6 |
luciferases - diagnostic use |
6 |
lumbar vertebrae - pathology |
6 |
lumbar vertebrae - pathology - radiography |
6 |
mecp2 |
6 |
mediation |
6 |
mental disorders / epidemiology |
6 |
meta-data |
6 |
metabolic diseases |
6 |
metabolic syndrome x - blood - epidemiology - etiology |
6 |
metabolic syndrome x - genetics |
6 |
metabolism |
6 |
mice, inbred c57bl |
6 |
mice, inbred strains |
6 |
minimum data set |
6 |
models, biological |
6 |